首页|期刊导航|解放军医学杂志|2011-2024年南阳市肺炎支原体流行预测模型的建立及分子流行病学特征分析

2011-2024年南阳市肺炎支原体流行预测模型的建立及分子流行病学特征分析OA

Establishment of a prediction model for Mycoplasma pneumoniae epidemic and analysis of molecular epidemiological characteristics in Nanyang from 2011 to 2024

中文摘要英文摘要

目的 分析南阳市肺炎支原体(MP)感染流行趋势、病原学特点和MP基因变异与进化情况,为临床实验室MP检测能力评估和疫情防控提供依据.方法 回顾性收集2011年1月-2024年3月南阳市中心医院收治的117 382例疑似MP感染患者的MP检测数据,分析MP感染的流行特点、耐药变迁、实验室检测方法学差异.基于R语言的时间序列分析,采用ARIMA模型对实验室检测MP-IgM阳性率进行建模,依据拟合优度统计量贝叶斯信息量准则(BIC),筛选最优的MP感染预测模型.通过美国GenBank数据库获取MP序列,参照MP原型株截取各分离株黏附蛋白(P1)区构建进化树并进行遗传变异分析.结果 2011-2024年,南阳市MP感染流行持续存在;2011-2019年MP感染与其他呼吸道多病原体交替或重合流行,2020-2022年呈MP单一流行且为上升趋势,而2023-2024年MP和甲型流感病毒(IAV)混合流行.MP感染患者以学龄前儿童为主.MP对大环内酯类抗生素的耐药与流行趋势相一致,呈"波浪形",平均耐药率>80%,以2024年耐药率最高,耐药突变均来自A2063G位点.荧光定量PCR法和一代测序法检测肺泡灌洗液MP-DNA具有显著优势.混合感染类型以MP-IAV多见,<14岁患者的混合感染还有MP-乙型流感病毒、MP-鼻病毒、MP-副流感病毒、MP-合胞病毒、MP-腺病毒.筛选的最优MP感染预测模型为ARIMA(2,1,3)(0,1,1)12,预测精度较高.与MP原型株相比,MP P1已发生不同程度进化,南阳市当前流行的基因型为MP P1-Ⅱ型.结论 南阳市MP感染持续流行;MP临床检验采用核酸和IgM联合检测较为合理;MP高耐药率和高混合感染亟须疫苗普及和抗生素合理使用.

Objective To analyze the epidemic trend,etiological characteristics,and genetic variation and evolution of Mycoplasma pneumoniae(MP)in Nanyang,thereby providing evidence for the assessment of clinical laboratory MP detection capabilities and epidemic prevention and control.Methods Retrospective collection was performed on MP detection data from 117,382 febrile patients admitted to Nanyang Central Hospital from January 2011 to March 2024.The epidemiological characteristics,drug resistance trends,and methodological differences in laboratory detection of MP infection were analyzed.Based on time-series analysis in R language,the ARIMA model was used to model the positive rate of laboratory-detected MP-IgM,and the optimal prediction model for MP infection was screened according to the Bayesian Information Criterion(BIC)of goodness-of-fit statistics.MP sequences were obtained from the GenBank database of the United States,and the adhesion protein(P1)region of each isolate was intercepted with reference to the MP prototype strain to construct a phylogenetic tree and perform genetic variation analysis.Results MP infection remained continuously epidemic in Nanyang from 2011 to 2024.From 2011 to 2019,MP infection occurred alternately or concurrently with other respiratory pathogens;from 2020 to 2022,MP showed a single epidemic with an upward trend;while from 2023 to 2024,mixed epidemics of MP and influenza A virus(IAV)were observed.Preschool children accounted for the majority of MP-infected patients.The resistance to macrolide antibiotics in MP was consistent with the epidemic trend,showing a wave pattern,with an average resistance rate exceeding 80%,peaking in 2024.All resistance mutations were located at the A2063G locus.Fluorescent quantitative PCR and Sanger sequencing(first-generation sequencing)showed significant advantages in detecting MP-DNA from bronchoalveolar lavage fluid.MP-IAV was the most common type of mixed infection.In patients under 14 years old,other mixed infections also included MP-influenza B virus,MP-rhinovirus,MP-parainfluenza virus,MP-respiratory syncytial virus,and MP-adenovirus.The optimal MP infection prediction model was screened as ARIMA(2,1,3)(0,1,1)12,which exhibited high predictive accuracy.Compared with the MP prototype strain,MP P1 had undergone varying degrees of evolution,and the current prevalent genotype in Nanyang was MP P1 type II.Conclusions MP infection is continuously prevalent in Nanyang.Combined detection of nucleic acid and IgM is reasonable for clinical MP testing.The high drug resistance rate and high mixed infection rate of MP necessitate widespread vaccination and rational use of clinical antibiotics.

汪海霞;吴岳;赵莹莹;冯扬帆;杜伟鹏;张舒林;周宏兵;龚豪;柴森

南阳市中心医院医学检验科,河南 南阳 473000南阳市中心医院医学检验科,河南 南阳 473000南阳市中心医院医学检验科,河南 南阳 473000南阳市中心医院医学检验科,河南 南阳 473000南阳市中心医院医学检验科,河南 南阳 473000上海交通大学基础医学院免疫学与微生物学系,上海 200025南阳师范学院数学与统计学院,河南 南阳 473061南阳市中心医院医学检验科,河南 南阳 473000南阳市中心医院医学检验科,河南 南阳 473000

医药卫生

肺炎支原体流行变迁实验室检测

Mycoplasma pneumoniaeepidemic changeslaboratory detection

《解放军医学杂志》 2026 (5)

675-683,9

This work was supported by the National Key Research and Development Program Project(2023YFE0199200),and the Nanyang City Key Scientific Research Project(KJGG091)国家重点研发计划项目(2023YFE0199200)南阳市科技攻关项目(KJGG091)

10.11855/j.issn.0577-7402.0253.2026.0402

评论